Skip to content

Press Releases

Date Title
05/05/2022 Illumina Reports Financial Results for First Quarter of Fiscal Year 2022
05/05/2022 Illumina and Deerfield Management partner to accelerate drug development
28/04/2022 Illumina To Webcast Upcoming Investor Conference
25/04/2022 Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
14/04/2022 Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
12/04/2022 Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center
11/04/2022 John Frank Joins Illumina as Chief Public Affairs Officer
07/04/2022 Illumina Releases Annual Corporate Social Responsibility Report
16/03/2022 Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
15/03/2022 Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
14/03/2022 Illumina Welcomes Carissa Rollins as Chief Information Officer
21/02/2022 Illumina To Webcast Upcoming Investor Conference
10/02/2022 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021
03/02/2022 Illumina To Webcast Upcoming Investor Conferences
03/02/2022 Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer
24/01/2022 Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
20/01/2022 Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022
10/01/2022 Illumina collaborates with Nashville Biosciences to accelerate medicines development
10/01/2022 Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care
10/01/2022 Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
10/01/2022 Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference
05/01/2022 Illumina Enters Co-Development Partnership with SomaLogic